Evaluation of clinical utility of novel coronavirus antigen detection reagent, Espline® SARS-CoV-2
To prevent the novel coronavirus disease 2019 (COVID-19) pandemic caused by SARS-CoV-2, it is necessary to perform early identification and isolation of people shedding the infectious virus in biological materials with high viral loads.
